Blood-free malaria screening for decentralized programs.
GoldN™ Easy-to-Use Urine Malaria Test is a urine-based malaria screening assay for public-health, community, and field deployment where blood collection and laboratory infrastructure are limited.
Not a U.S. consumer product. Not sold on areyougoldn.com.
Urine-based malaria screening without a blood draw.
GoldN™ Easy-to-Use Urine Malaria Test supports screening programs that need a simple sample type, reduced biohazard handling, and operation outside traditional laboratories.
Blood-free sample
Urine collection removes the need for fingerstick or venous blood in the screening workflow.
Eliminates blood collection for this screening workflow.
Healthcare workers, NGOs, and authorized organizations.
Clinical, community, and limited-infrastructure sites.
Antigen presence or absence with a control-line check.
A negative result does not rule out malaria.
Built for simple, decentralized screening.
The workflow prioritizes minimal training burden and clear visual interpretation for program deployment.
Collect urine sample
Obtain the urine sample per program protocol.
Run the assay
Apply sample to the test cassette according to instructions.
Wait for development
Allow the strip to develop the control and test line pattern.
Read the result
Interpret the visual qualitative result. Confirmatory clinical assessment remains available when symptoms persist.
Blood-free sampling. Field deployment. Clear visual readout.
Built for malaria screening programs that need operational simplicity without laboratory dependency.
Blood-free collection
Urine sample removes phlebotomy from the screening step.
Decentralized use
Supports community and field sites with limited lab access.
Program audiences
Healthcare workers, NGOs, and institutional buyers.
Companion path
GoldN Companion is in development for connected workflows.
Where urine malaria screening fits operationally.
Category comparison for procurement and program design discussions. Not a performance league table.
| Metric | GoldN™ Easy-to-Use Urine Malaria Test | Typical blood malaria RDT |
|---|---|---|
| Sample | Urine | Capillary or venous blood |
| Blood collection | Not required for this assay | Required |
| Setting emphasis | Decentralized / community / field | Clinic and community (varies by product) |
| Result type | Visual qualitative screen | Visual qualitative screen (typical) |
| Primary users | Program staff and authorized organizations | Clinicians and community health workers |
| U.S. consumer retail | No | Varies; this GoldN program is not sold as a U.S. consumer product |
Sample
Blood collection
Setting emphasis
Result type
Primary users
U.S. consumer retail
GoldN Companion for connected screening programs.
GoldN™ Easy-to-Use Urine Malaria Test is a visual assay for program use. GoldN Companion is in development for connected workflows.
- The urine malaria test can be read visually today.
- GoldN Companion is in development and not available for sale.
- Not cleared or approved by the FDA.
GoldN Companion video
The video shows the companion concept and the workflow direction for connected screening programs.
NOVODX works with public-health programs and distributors.
Governments, NGOs, and authorized organizations can request program information, evaluation supply, and procurement discussions.
Contact NOVODXPublic-health screening outside the U.S. consumer market.
This chapter is a public-health program page. It is not a U.S. consumer product and is not sold on areyougoldn.com.
Program questions in plain clinical language.
What type of malaria does the test screen for?
The assay is designed to screen for malaria caused by Plasmodium falciparum, the species responsible for the majority of malaria cases in Africa.
What sample type does the test use?
The test uses a urine sample, eliminating the need for blood collection. This reduces biohazard risk and simplifies screening in community and decentralized settings.
Who is the intended user?
Healthcare workers, public health programs, NGOs, and authorized organizations conducting malaria screening activities. Adult supervision is required when used for children.
Where can the test be used?
Clinical, community, and field settings, including areas with limited laboratory infrastructure.
How are results interpreted?
The test provides a visual result indicating the presence or absence of malaria antigens in urine. A control line confirms proper test function. Results are qualitative and intended for screening purposes.
Does a negative result rule out malaria?
No. A negative result does not definitively rule out malaria. If symptoms persist, further clinical assessment and confirmatory testing are recommended.
How can organizations request pricing or bulk supply?
Governments, NGOs, and distributors may request pricing and availability by contacting NOVODX through this website.


